{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:54:36Z","timestamp":1791071676151,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21HL089816"],"award-info":[{"award-number":["R21HL089816"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001692","name":"Croucher Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.biomaterials.2011.05.008","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T20:04:13Z","timestamp":1309032253000},"page":"6285-6290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"title":["Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus"],"prefix":"10.1016","volume":"32","author":[{"given":"Samuel K.","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Soo","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olcay","family":"Mert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeane","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2011.05.008_bib1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11882-004-0031-3","article-title":"Olfaction and anosmia in rhinosinusitis","volume":"4","author":"Dalton","year":"2004","journal-title":"Current Allergy and Asthma Reports"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/hn.2003.v128.amhn0312811","article-title":"Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology","volume":"129","author":"Benninger","year":"2003","journal-title":"Otolaryngology\u2013Head & Neck Surgery"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2005.03.049","article-title":"Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis","volume":"116","author":"Ponikau","year":"2005","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2008.02.009","article-title":"Induction of B7-H1 and B7-DC expression on airway epithelial cells by the toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: in\u00a0vivo and in\u00a0vitro studies","volume":"121","author":"Heinecke","year":"2008","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaci.2003.08.009","article-title":"Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma?","volume":"112","author":"Ponikau","year":"2003","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000093757","article-title":"Chronic rhinosinusitis and olfactory dysfunction","volume":"63","author":"Raviv","year":"2006","journal-title":"Advances in Oto-rhino-laryngology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/archotol.1997.01900040009001","article-title":"Topical corticosteroid treatment of anosmia associated with nasal and sinus disease","volume":"123","author":"Mott","year":"1997","journal-title":"Archives of Otolaryngology\u2013Head & Neck Surgery"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1081-1206(10)63155-9","article-title":"Diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy, asthma and immunology","volume":"81","author":"Dykewicz","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nbt876","article-title":"Small scale systems for in\u00a0vivo drug delivery","volume":"21","author":"LaVan","year":"2003","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrd1721","article-title":"The rise and rise of drug delivery","volume":"4","author":"Rosen","year":"2005","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib12","series-title":"Mucosal immunlogy","first-page":"43","article-title":"Mucus","author":"Cone","year":"1999"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib13","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib14","doi-asserted-by":"crossref","first-page":"50393","DOI":"10.1074\/jbc.M309026200","article-title":"Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport","volume":"278","author":"Dawson","year":"2003","journal-title":"Journal of Biological Chemistry."},{"key":"10.1016\/j.biomaterials.2011.05.008_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro- and macrorheology of mucus","volume":"61","author":"Lai","year":"2009","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib16","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.biomaterials.2008.12.076","article-title":"The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles","volume":"30","author":"Suk","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib17","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2004.06.001","article-title":"Real-time multiple-particle tracking: applications to drug and gene delivery","volume":"57","author":"Suh","year":"2005","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib19","first-page":"461","article-title":"Quantifying the intracellular transport of viral and nonviral gene vectors in primary neurons","volume":"232","author":"Suk","year":"2007","journal-title":"Experimental Biology and Medicine"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1023\/A:1018908421434","article-title":"Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release","volume":"16","author":"Yoo","year":"1999","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib22","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1021\/ma980765f","article-title":"Solute diffusion within hydrogels. Mechanisms and models","volume":"31","author":"Amsden","year":"1998","journal-title":"Macromolecules"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib23","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1021\/ma980922a","article-title":"An obstruction-scaling model for diffusion in homogeneous hydrogels","volume":"32","author":"Amsden","year":"1999","journal-title":"Macromolecules"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib24","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1529\/biophysj.105.077404","article-title":"DNA diffusion in mucus: effect of size, topology of DNAs, and transfection reagents","volume":"91","author":"Shen","year":"2006","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0142-9612(96)81421-9","article-title":"In vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glycolide)","volume":"17","author":"Ignatius","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jbm.820190315","article-title":"Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules","volume":"19","author":"Visscher","year":"1985","journal-title":"Journal of Biomedical Materials Research"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib29","series-title":"Inactive ingredient search for approved drug products, \u201cpoloxamer\u201d","year":"2011"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib30","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"Angewandte Chemie International Edition"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0022-5347(05)00161-8","article-title":"A\u00a012-month clinical study of LA-2585 (45.0 MG): a new 6-month subcutaneous delivery system for leuprolide acetate for the treatment of prostate cancer","volume":"175","author":"Crawford","year":"2006","journal-title":"The Journal of Urology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.0303-6979.2004.00494.x","article-title":"Comparison of the pharmacokinetic profiles of two locally administered doxycycline gels in crevicular fluid and saliva","volume":"31","author":"Kim","year":"2004","journal-title":"Journal of Clinical Periodontology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-051X.2003.00017.x","article-title":"A\u00a0placebo-controlled multi-centred evaluation of an anaesthetic gel (Oraqix) for periodontal therapy","volume":"30","author":"Donaldson","year":"2003","journal-title":"Journal of Clinical Periodontology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1517\/13543784.7.7.1193","article-title":"FLOCOR: a new anti-adhesive, rheologic agent","volume":"7","author":"Emanuele","year":"1998","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s002280050008","article-title":"Pharmacokinetics and bioequivalence evaluation of three commercial tablet formulations of mefloquine when given in combination with dihydroartemisinin in patients with acute uncomplicated falciparum malaria","volume":"55","author":"Na-Bangchang","year":"2000","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archderm.142.5.597","article-title":"Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study","volume":"142","author":"Thiboutot","year":"2006","journal-title":"Archives of Dermatology"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-409X(97)00049-5","article-title":"Preparation of microspheres by the solvent evaporation technique","volume":"28","author":"McGinity","year":"1997","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib38","doi-asserted-by":"crossref","first-page":"e4294","DOI":"10.1371\/journal.pone.0004294","article-title":"Altering mucus rheology to \u201csolidify\u201d human mucus at the nanoscale","volume":"4","author":"Lai","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.2006.01744.x","article-title":"Evidence for airway surface dehydration as the initiating event in CF airway disease","volume":"261","author":"Boucher","year":"2007","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archotol.131.3.237","article-title":"Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation","volume":"131","author":"Wang","year":"2005","journal-title":"Archives of Otolaryngology\u2013Head & Neck Surgery"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib41","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/jama.284.14.1814","article-title":"Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population","volume":"284","author":"Wang","year":"2000","journal-title":"Jama"},{"key":"10.1016\/j.biomaterials.2011.05.008_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2217\/nnm.10.123","article-title":"Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine","volume":"6","author":"Suk","year":"2011","journal-title":"Nanomedicine (Lond)"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121100514X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121100514X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:31:43Z","timestamp":1758900703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121100514X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":42,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S014296121100514X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.05.008","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2011.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}